Avidity Biosciences Inc (RNA)
42.56
-1.09
(-2.50%)
USD |
NASDAQ |
Nov 21, 16:00
42.55
-0.01
(-0.02%)
After-Hours: 20:00
Avidity Biosciences Total Liabilities (Quarterly): 137.39M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 137.39M |
| June 30, 2024 | 126.39M |
| March 31, 2024 | 120.58M |
| December 31, 2023 | 127.79M |
| September 30, 2023 | 55.70M |
| June 30, 2023 | 51.61M |
| March 31, 2023 | 55.06M |
| December 31, 2022 | 60.72M |
| September 30, 2022 | 53.56M |
| June 30, 2022 | 46.45M |
| Date | Value |
|---|---|
| March 31, 2022 | 45.43M |
| December 31, 2021 | 46.15M |
| September 30, 2021 | 31.04M |
| June 30, 2021 | 26.04M |
| March 31, 2021 | 28.64M |
| December 31, 2020 | 27.68M |
| September 30, 2020 | 25.97M |
| June 30, 2020 | 25.06M |
| March 31, 2020 | 26.68M |
| December 31, 2019 | 162.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.06M
Minimum
Jun 2020
162.26M
Maximum
Dec 2019
64.01M
Average
49.03M
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 2.379B |
| Vertex Pharmaceuticals Inc | 6.609B |
| Natera Inc | 712.42M |
| Entrada Therapeutics Inc | 132.14M |
| Alnylam Pharmaceuticals Inc | 4.173B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.641B |
| Shareholders Equity (Quarterly) | 1.503B |
| Current Ratio | 17.76 |